Hsp70 in Cancer: Partner or Traitor to Immune System

  • Mehdi Asghari Vostakolaei Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran AND Department of Pharmaceutical Biotechnology, Faculty of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
  • Jalal Abdolalizadeh Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran AND Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
  • Mohammad Saeid Hejazi Department of Pharmaceutical Biotechnology, Faculty of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran AND Department of Molecular Medicine, School of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran AND Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
  • Shirafkan Kordi Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
  • Ommoleila Molavi Department of Pharmaceutical Biotechnology, Faculty of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran AND Biotechnology Research Center, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Keywords:
Apoptosis, Cancer vaccines, Heat shock protein 70 (Hsp70), Single-chain variable fragment antibody, Tumor microenvironment

Abstract

Heat shock protein 70.1 (Hsp70.1), also known as Hsp70, is a highly conserved member of the heat shock protein family that exists in all living organisms and determines the protein fate as molecular chaperones. Hsp70 basal expression is undetectable or low in most unstressed normal cells, however, its abundant presence in several types of human cancer cells is reported. Several studies support upregulated Hsp70 involved in tumor progression and drug resistance through modulation of cell death pathways and suppresses anticancer immune responses. However, numerous studies have confirmed that Hsp70 can also induce anticancer immune responses through the activation of immune cells in particular antigen-presenting cells (APCs). Regarding the significant and the promising role of vaccines in cancer immunotherapy, identification and characterization of the overexpressed Hsp70 as a potential immune stimulatory factor can pave the path for development of highly effective anticancer vaccines. In this review, we will discuss the interactions of Hsp70 with components of the immune system in cancers as well as possible strategies to harness Hsp70 for eliciting anticancer immune responses.

References

1. Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Advanced Drug Delivery Reviews 2009; 61(4):310-8.
2. Saghafi N, Pourali L, Ghavami Ghanbarabadi V, Mirzamarjani F, Mirteimouri M. Serum heat shock protein 70 in preeclampsia and normal pregnancy: A systematic review and meta-analysis. International Journal of Reproductive BioMedicine 2018; 16(1):1-8.
3. Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunology, Immunotherapy 2006; 55(3):312-9.
4. Boudesco C, Cause S, Jego G, Garrido C. Hsp70: A Cancer Target Inside and Outside the Cell. In: Calderwood SK, Prince TL, editors. Chaperones: Methods and Protocols. New York, NY: Springer New York; 2018. p. 371-96.
5. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Høyer-Hansen M, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. Journal of Experimental Medicine 2004; 200(4):425-35.
6. Doulias P-T, Kotoglou P, Tenopoulou M, Keramisanou D, Tzavaras T, Brunk U, et al. Involvement of heat shock protein-70 in the mechanism of hydrogen peroxide-induced DNA damage: the role of lysosomes and iron. Free Radical Biology and Medicine 2007; 42(4):567-77.
7. Bivik C, Rosdahl I, Öllinger K. Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis 2007; 28(3):537-44.
8. Murakami N, Kühnel A, Schmid TE, Ilicic K, Stangl S, Braun IS, et al. Role of membrane Hsp70 in radiation sensitivity of tumor cells. Radiation Oncology 2015; 10(1):149.
9. Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, et al. Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome research 2003; 13(12):2621-36.
10. Goate AM, Cooper DN, Hall C, Leung TK, Solomon E, Lim L. Localization of a human heat-shock HSP 70 gene sequence to chromosome 6 and detection of two other loci by somatic-cell hybrid and restriction fragment length polymorphism analysis. Human genetics 1987; 75(2):123-8.
11. Milner CM, Campbell RD. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 1990; 32(4):242-51.
12. Saibil H. Chaperone machines for protein folding, unfolding and disaggregation. Nature reviews Molecular cell biology 2013; 14(10):630.
13. Milarski KL, Morimoto RI. Expression of human HSP70 during the synthetic phase of the cell cycle. Proceedings of the National Academy of Sciences 1986; 83(24):9517-21.
14. Taira T, Narita T, Iguchi-Ariga SM, Ariga H. A novel G 1-specific enhancer identified in the human heat shock protein 70 gene. Nucleic acids research 1997; 25(10):1975-83.
15. Brocchieri L, De Macario EC, Macario AJ. hsp70 genes in the human genome: Conservation and differentiation patterns predict a wide array of overlapping and specialized functions. BMC evolutionary biology 2008; 8(1):19.
16. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science 2015; 347(6220):1260419.
17. Dix DJ, Allen JW, Collins BW, Poorman-Allen P, Mori C, Blizard DR, et al. HSP70-2 is required for desynapsis of synaptonemal complexes during meiotic prophase in juvenile and adult mouse spermatocytes. Development 1997; 124(22):4595-603.
18. Zakeri ZF, Wolgemuth DJ. Developmental-stage-specific expression of the hsp70 gene family during differentiation of the mammalian male germ line. Molecular and cellular biology 1987; 7(5):1791-6.
19. Liu P, Yu S, Cui Y, He J, Zhang Q, Liu J, et al. Regulation by HSP70/90 in the different tissues and testis development of male cattle (Cattle-yak and Yak). bioRxiv 2018:393371.
20. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. Journal of molecular graphics 1996; 14(1):33-8.
21. Fulop T, Larbi A, Pawelec G. Human T Cell Aging and the Impact of Persistent Viral Infections. Frontiers in Immunology 2013; 4(271).
22. Rea I, McNerlan S, Pockley A. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Experimental gerontology 2001; 36(2):341-52.
23. Terry DF, McCORMICK M, Andersen S, Pennington J, Schoenhofen E, Palaima E, et al. Cardiovascular disease delay in centenarian offspring: role of heat shock proteins. Annals of the New York Academy of Sciences 2004; 1019(1):502-5.
24. Molvarec A, Rigó Jr J, Nagy B, Walentin S, Szalay J, Füst G, et al. Serum heat shock protein 70 levels are decreased in normal human pregnancy. Journal of reproductive immunology 2007; 74(1-2):163-9.
25. Qu B, Jia Y, Liu Y, Wang H, Ren G, Wang H. The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review. Cell Stress and Chaperones 2015; 20(6):885-92.
26. Sherman MY, Gabai VL. Hsp70 in cancer: back to the future. Oncogene 2014; 34:4153.
27. Shin BK, Wang H, Yim AM, Le Naour F, Brichory F, Jang JH, et al. Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function. Journal of Biological Chemistry 2003; 278(9):7607-16.
28. Kleinjung T, Arndt O, Feldmann HJ, Bockmühl U, Gehrmann M, Zilch T, et al. Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy—a target for natural killer (NK) cells. International Journal of Radiation Oncology Biology Physics 2003; 57(3):820-6.
29. Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann W, Multhoff G. Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 2003; 88(4):474-6.
30. Botzler C, Kolb H-J, Issels RD, Multhoff G. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. International Journal of Cancer 1996; 65(5):633-8.
31. Gehrmann M, Pfister K, Hutzler P, Gastpar R, Margulis B, Multhoff G. Effects of Antineoplastic Agents on Cytoplasmic and Membrane-Bound Heat Shock Protein 70 (Hsp70) Levels. Biological Chemistry 2002. p. 1715.
32. Gehrmann M, Brunner M, Pfister K, Reichle A, Kremmer E, Multhoff G. Differential Up-Regulation of Cytosolic and Membrane-Bound Heat Shock Protein 70 in Tumor Cells by Anti-Inflammatory Drugs. Clinical Cancer Research 2004; 10(10):3354-64.
33. Korbelik M, Sun J, Cecic I. Photodynamic Therapy–Induced Cell Surface Expression and Release of Heat Shock Proteins: Relevance for Tumor Response. Cancer Research 2005; 65(3):1018-26.
34. Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. Radiotherapy and Oncology 2010; 95(3):350-8.
35. Wicha MS, Hayes DF. Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected. Journal of Clinical Oncology 2011; 29(12):1508-11.
36. Breuninger S, Stangl S, Werner C, Sievert W, Lobinger D, Foulds GA, et al. Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition. Frontiers in Oncology 2018; 8(497).
37. Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, Wilmanns W, et al. A stress‐inducible 72‐kDa heat‐shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. International journal of cancer 1995; 61(2):272-9.
38. Gehrmann M, Specht HM, Bayer C, Brandstetter M, Chizzali B, Duma M, et al. Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiation Oncology 2014; 9(1):131.
39. Mambula SS, Calderwood SK. Heat Shock Protein 70 Is Secreted from Tumor Cells by a Nonclassical Pathway Involving Lysosomal Endosomes. The Journal of Immunology 2006; 177(11):7849-57.
40. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. International Immunology 2000; 12(11):1539-46.
41. Evdonin AL, Martynova MG, Bystrova OA, Guzhova IV, Margulis BA, Medvedeva ND. The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules. European Journal of Cell Biology 2006; 85(6):443-55.
42. Harada Y, Sato C, Kitajima K. Complex formation of 70-kDa heat shock protein with acidic glycolipids and phospholipids. Biochemical and Biophysical Research Communications 2007; 353(3):655-60.
43. Lancaster GI, Febbraio MA. Exosome-dependent Trafficking of HSP70: A NOVEL SECRETORY PATHWAY FOR CELLULAR STRESS PROTEINS. Journal of Biological Chemistry 2005; 280(24):23349-55.
44. Kahroba H, Hejazi MS, Samadi N. Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cellular and Molecular Life Sciences 2019.
45. Vega VL, Rodríguez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, et al. Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages. The Journal of Immunology 2008; 180(6):4299-307.
46. Arispe N, Doh M, De Maio A. Lipid interaction differentiates the constitutive and stress-induced heat shock proteins Hsc70 and Hsp70. Cell stress & chaperones 2002; 7(4):330-8.
47. Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Research 2015; 43(Database issue):D405-12.
48. Simon AK, Hollander Georg A, McMichael A. Evolution of the immune system in humans from infancy to old age. Proceedings of the Royal Society B: Biological Sciences 2015; 282(1821):20143085.
49. Kuppner MC, Gastpar R, Gelwer S, Nössner E, Ochmann O, Scharner A, et al. The role of heat shock protein (hsp70) in dendritic cell maturation: Hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. European Journal of Immunology 2001; 31(5):1602-9.
50. Wang Y, Whittall T, McGowan E, Younson J, Kelly C, Bergmeier LA, et al. Identification of Stimulating and Inhibitory Epitopes within the Heat Shock Protein 70 Molecule That Modulate Cytokine Production and Maturation of Dendritic Cells. The Journal of Immunology 2005; 174(6):3306-16.
51. Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004; 64(4):442-51.
52. Thériault JR, Adachi H, Calderwood SK. Role of Scavenger Receptors in the Binding and Internalization of Heat Shock Protein 70. The Journal of Immunology 2006; 177(12):8604-11.
53. Thériault JR, Mambula SS, Sawamura T, Stevenson MA, Calderwood SK. Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Letters 2005; 579(9):1951-60.
54. Mohammadi H, Sharafkandi N, Hemmatzadeh M, Azizi G, Karimi M, Jadidi-Niaragh F, et al. The role of innate lymphoid cells in health and disease. Journal of Cellular Physiology 2018; 233(6):4512-29.
55. Shabgah AG, Navashenaq JG, Shabgah OG, Mohammadi H, Sahebkar A. Interleukin-22 in human inflammatory diseases and viral infections. Autoimmunity Reviews 2017; 16(12):1209-18.
56. Rahmatpanah F, Agrawal S, Scarfone VM, Kapadia S, Mercola D, Agrawal A. Transcriptional Profiling of Age-Associated Gene Expression Changes in Human Circulatory CD1c+ Myeloid Dendritic Cell Subset. The Journals of Gerontology: Series A 2018; 74(1):9-15.
57. Gross C, Hansch D, Gastpar R, Multhoff G. Interaction of Heat Shock Protein 70 Peptide with NK Cells Involves the NK Receptor CD94. Biological Chemistry2003. p. 267.
58. Multhoff G, Mizzen L, Winchester CC, Milner CM, Wenk S, Eissner G, et al. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Experimental Hematology 1999; 27(11):1627-36.
59. Multhoff G, Pfister K, Gehrmann M, Hantschel M, Gross C, Hafner M, et al. A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell stress & chaperones 2001; 6(4):337.
60. Multhoff G. Heat shock protein 70 (Hsp70): Membrane location, export and immunological relevance. Methods 2007; 43(3):229-37.
61. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, et al. Heat Shock Protein 70 Surface-Positive Tumor Exosomes Stimulate Migratory and Cytolytic Activity of Natural Killer Cells. Cancer Research 2005; 65(12):5238-47.
62. Asea A, Kraeft S-K, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nature Medicine 2000; 6:435.
63. Panjwani NN, Popova L, Srivastava PK. Heat Shock Proteins gp96 and hsp70 Activate the Release of Nitric Oxide by APCs. The Journal of Immunology 2002; 168(6):2997-3003.
64. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in Inflammation and Cancer. Annual Review of Immunology 2010; 28(1):367-88.
65. Somensi N, Brum PO, de Miranda Ramos V, Gasparotto J, Zanotto-Filho A, Rostirolla DC, et al. Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells. Cellular Physiology and Biochemistry 2017; 42(6):2507-22.
66. Elsner L, Flügge PF, Lozano J, Muppala V, Eiz-Vesper B, Demiroglu SY, et al. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. Journal of Cellular and Molecular Medicine 2010; 14(4):992-1002.
67. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee H-G, de la Salle H, et al. Cutting Edge: Receptor-Mediated Endocytosis of Heat Shock Proteins by Professional Antigen-Presenting Cells. The Journal of Immunology 1999; 162(7):3757-60.
68. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJS, Kuppner MC, et al. Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells. The Journal of Immunology 2002; 169(10):5424-32.
69. Takemoto S, Nishikawa M, Guan X, Ohno Y, Yata T, Takakura Y. Enhanced Generation of Cytotoxic T Lymphocytes by Heat Shock Protein 70 Fusion Proteins Harboring Both CD8+ T Cell and CD4+ T Cell Epitopes. Molecular Pharmaceutics 2010; 7(5):1715-23.
70. Udono H, Levey DL, Srivastava PK. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proceedings of the National Academy of Sciences 1994; 91(8):3077-81.
71. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin J-P, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. The Journal of Clinical Investigation 2010; 120(2):457-71.
72. Wachstein J, Tischer S, Figueiredo C, Limbourg A, Falk C, Immenschuh S, et al. HSP70 Enhances Immunosuppressive Function of CD4+CD25+FoxP3+ T Regulatory Cells and Cytotoxicity in CD4+CD25− T Cells. PLOS ONE 2012; 7(12):e51747.
73. Lee K-J, Kim YM, Kim DY, Jeoung D, Han K, Lee S-T, et al. Release of heat shock protein 70 (Hsp70) and the effects of extracellular Hsp70 on matric metalloproteinase-9 expression in human monocytic U937 cells. Experimental &Amp; Molecular Medicine 2006; 38:364.
74. Sims JD, McCready J, Jay DG. Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion. PLOS ONE 2011; 6(4):e18848.
75. Jang J, Kim MR, Kim T-K, Lee WR, Kim JH, Heo K, et al. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis. Scientific Reports 2017; 7(1):10666.
76. Kasioumi P, Vrazeli P, Vezyraki P, Zerikiotis S, Katsouras C, Damalas A, et al. Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells. International journal of oncology 2019; 54(3):821-32.
77. Li Z, Qiao Y, Liu B, Laska EJ, Chakravarthi P, Kulko JM, et al. Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia. Clinical Cancer Research 2005; 11(12):4460-8.
78. Specht HM, Ahrens N, Blankenstein C, Duell T, Fietkau R, Gaipl US, et al. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial. Frontiers in Immunology 2015; 6(162).
79. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, Sievert W, et al. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proceedings of the National Academy of Sciences 2011; 108(2):733-8.
80. Gehrmann MK, Kimm MA, Stangl S, Schmid TE, Noël PB, Rummeny EJ, et al. Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticles. International journal of nanomedicine 2015; 10:5687-700.
81. Kordi S, Rahmati-Yamchi M, Vostakolaei MA, Etemadi A, Barzegari A, Abdolalizadeh J. Isolation of a Novel Anti-KDR3 Single-chain Variable Fragment Antibody from a Phage Display Library. Iranian Journal of Allergy, Asthma and Immunology 2018:1-11.
82. Vostakolaei MA, Molavi O, Hejazi MS, Kordi S, Rahmati S, Barzegari A, et al. Isolation and characterization of a novel scFv antibody fragments specific for Hsp70 as a tumor biomarker. Journal of Cellular Biochemistry.
83. Kordi S, Rahmati-Yamchi M, Asghari Vostakolaei M, Barzegari A, Abdolalizadeh J. Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragmentand Evaluation of Binding Affinity by Surface Plasmon Resonance. Adv Pharm Bull 2019; 9(1):64-9.
84. Jensen TI, Axelgaard E, Bak RO. Therapeutic gene editing in haematological disorders with CRISPR/Cas9. British Journal of Haematology 2019; 185(5):821-35.
85. Smith J, Valton J, Juillerat A, Duchateau P, Sasu Barbra J, Rajpal A, inventors; CELLECTIS
RINAT NEUROSCIENCE CORP, assignee. Anti-hsp70 Specific Chimeric Antigen Receptors (cars) For Cancer Immunotherapy. US patent: US20180000914A1 patent US20180000914A1. 2016 2016/01/25.
86. Shevtsov M, Multhoff G. Therapeutic Implications of Heat Shock Proteins in Cancer. In: Asea AAA, Kaur P, editors. Chaperokine Activity of Heat Shock Proteins. Cham: Springer International Publishing; 2019. p. 211-43.
87. Mortaz E, Redegeld FA, Nijkamp FP, Wong HR, Engels F. Acetylsalicylic acid–induced release of HSP70 from mast cells results in cell activation through TLR pathway. Experimental Hematology 2006; 34(1):8-18.
88. Etminan N, Peters C, Lakbir D, Bünemann E, Börger V, Sabel MC, et al. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. British Journal Of Cancer 2011; 105:961.
89. Massa C, Guiducci C, Arioli I, Parenza M, Colombo MP, Melani C. Enhanced Efficacy of Tumor Cell Vaccines Transfected with Secretable hsp70. Cancer Research 2004; 64(4):1502-8.
90. Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, et al. Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells. The Journal of Immunology 2006; 177(9):5946-55.
91. Geng H, Zhang G-M, Xiao H, Yuan Y, Li D, Zhang H, et al. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. International Journal of Cancer 2006; 118(11):2657-64.
92. Liu B, Ye D, Song X, Zhao X, Yi L, Song J, et al. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 2008; 26(10):1387-96.
93. Kumar S, Deepak P, Acharya A. Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice. Neoplasma 2009; 56(3):259-68.
94. Wang X-P, Lin H-P, Wang Q-X, Gu Y. Specific Antitumor Immunity Induced by Cross-linking Complex Heat Shock Protein 72 and Alpha-fetoprotein. Cancer Biotherapy and Radiopharmaceuticals 2012; 27(3):189-97.
95. Abkin SV, Pankratova KM, Komarova EY, Guzhova IV, Margulis BA. Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool. Cell Stress and Chaperones 2013; 18(3):391-6.
96. Shevtsov MA, Pozdnyakov AV, Mikhrina AL, Yakovleva LY, Nikolaev BP, Dobrodumov AV, et al. Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70. International Journal of Cancer 2014; 135(9):2118-28.
97. Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, Arrifin NH, et al. A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma. Journal of Hematology & Oncology 2014; 7(1):15.
98. Liu T-T, Wu Y, Niu T. Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma. Oncotarget 2018;9(1):178.
99. Balogi Z, Multhoff G, Jensen TK, Lloyd-Evans E, Yamashima T, Jäättelä M, et al. Hsp70 interactions with membrane lipids regulate cellular functions in health and disease. Progress in Lipid Research 2019; 74:18-30.
100.Ivanov AA, Khuri FR, Fu H. Targeting protein–protein interactions as an anticancer strategy. Trends in Pharmacological Sciences 2013; 34(7):393-400.
101.Hanahan D, Weinberg Robert A. Hallmarks of Cancer: The Next Generation. Cell 2011; 144(5):646-74.
102.Mo L, Chen Q, Zhang X, Shi X, Wei L, Zheng D, et al. Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer Vaccine 2017; 35(43):5932-8.
103.Evdonin AL, Kropacheva IV, Medvedeva ND. Extracellular Hsp70 stimulates multiple signaling pathways in A431 carcinoma cells. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 2009; 3(3):291-7.
104.Wu F-H, Yuan Y, Li D, Liao S-J, Yan B, Wei J-J, et al. Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance. Cancer Letters 2012; 317(2):157-64.
105.Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, et al. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine 2008; 26(39):5046-57.
106.Sambi M, Bagheri L, Szewczuk MR. Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates. Journal of Oncology. 2019; 2019:12.
Published
2019-12-04
How to Cite
1.
Vostakolaei M, Abdolalizadeh J, Hejazi MS, Kordi S, Molavi O. Hsp70 in Cancer: Partner or Traitor to Immune System. Iran J Allergy Asthma Immunol. 18(6):589-604.
Section
Review Article(s)